Shares of CHF Solutions Inc (NASDAQ:CHFS) have received an average broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy recommendation.

Analysts have set a 12-month consensus target price of $3.15 for the company and are expecting that the company will post ($0.59) earnings per share for the current quarter, according to Zacks. Zacks has also assigned CHF Solutions an industry rank of 108 out of 255 based on the ratings given to its competitors.

CHFS has been the topic of a number of analyst reports. ValuEngine upgraded CHF Solutions from a “hold” rating to a “buy” rating in a research report on Monday, July 2nd. Zacks Investment Research lowered CHF Solutions from a “buy” rating to a “hold” rating in a research report on Tuesday. Finally, Dawson James assumed coverage on CHF Solutions in a research report on Tuesday, August 28th. They set a “buy” rating and a $3.30 target price on the stock.

In other CHF Solutions news, CEO John L. Erb bought 23,584 shares of the business’s stock in a transaction that occurred on Tuesday, July 3rd. The shares were bought at an average price of $2.12 per share, for a total transaction of $49,998.08. The purchase was disclosed in a filing with the SEC, which is available through this link. 3.50% of the stock is owned by corporate insiders.

Institutional investors have recently made changes to their positions in the stock. Perkins Capital Management Inc. bought a new stake in shares of CHF Solutions during the 2nd quarter valued at about $108,000. Dimensional Fund Advisors LP bought a new stake in shares of CHF Solutions during the 2nd quarter valued at about $161,000. Finally, Sabby Management LLC boosted its position in shares of CHF Solutions by 243.9% during the 1st quarter. Sabby Management LLC now owns 180,498 shares of the company’s stock valued at $504,000 after purchasing an additional 128,008 shares in the last quarter. Institutional investors own 20.58% of the company’s stock.

NASDAQ CHFS opened at $1.20 on Tuesday. CHF Solutions has a 12 month low of $0.93 and a 12 month high of $24.45.

CHF Solutions (NASDAQ:CHFS) last released its quarterly earnings results on Tuesday, August 7th. The company reported ($0.93) EPS for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.01). CHF Solutions had a negative net margin of 471.94% and a negative return on equity of 166.88%. The company had revenue of $1.10 million during the quarter. sell-side analysts anticipate that CHF Solutions will post -2.9 EPS for the current year.

CHF Solutions Company Profile

CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.

Featured Article: Outstanding Shares, Buying and Selling Stocks

Get a free copy of the Zacks research report on CHF Solutions (CHFS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CHF Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CHF Solutions and related companies with MarketBeat.com's FREE daily email newsletter.